RE: The "Exhumation of Eden" - Yeah, should have been an NR I would have NR'd the start of Eden, but that is just me....
Here is the detail of Eden "buried within the MD&A..I'm quite certain ALL retailers read the "MD&A" don't they? ; - )
Bear in mind, they pulled the same move when the arrangement with Toray on the 5yr extstension of the PMX deal was done. They "MD&A'd it"..but close to ONE year after it's completion.
Here is the "SUB-trial" just launched, nice cuz it could ramp up TIGRIS numbers without the public being aware. I'm still waiting for the Covid Trial results to be shared. Sending out the recording of the complicit professor chatting with the former pot exec doesn't count "Donnie" ; - )
In March 2022, the Company launched an ancillary observational study, EDEN, to collect data on patients with sepsis even if ineligible for Tigris. EDEN will capture much needed data on the full range of septic shock and its relation to organ failure and endotoxin activity. These data will inform subsequent discussions with the FDA on labelling for PMX as well as to provide the medical community and the Company a better picture of the addressable population in the U.S. for PMX. Furthermore, patients enrolled in EDEN will also be considered for entry into Tigris study, which provides another tool to support enrollment.